4Breumwald E, Antman EM, Beasley JW, et al. ACC/AHA guidelines for the management of patients with unstable angina and non-Stsegment elevation myocardial infarction:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines(Committee on the management of Patents With Unstable Angina)[ J].J Am Coll Cardiol,2000,36(7):2976-2992.
5Steinhubl SR, Tan WA, Foody JM, et al. Incidence and clinical course of thrombotic thrombocytopenic purpura due to ticlopidine following coronary stenting [ J ]. JAMA, 1999,281 (9) : 806-810.
6Bennett CL, Davidsen CJ, Raisch DW, et al. Thrombotic thrombocytopenic purpura associated with ticlopidine in the setting of coronary artery stents and stroke prevention [ J ]. Arch Intern Med, 1999,159 ( 21 ) :2524-2528.
7Zusman RM, Chesebro JH, Comerota A, et ai. Antiplatelet therapy in the prevention of ischemic vascular events: literature review and evidence-based guid clines for drug selection [ J ]. Clin Cardiol, 1999,22(9) : 559-573.
8Klein W, Buchwald A, Hillis SE, et al. Comparison of low-molecular-weight heparin with unfractionated heparin acutely and with placebo for 6 weeks in the management of unstable coronary artery disease. Fragmin In unstable Coronary artery disease ( FRIC ) [ J ]. Circulation, 1997,96(10) :61-68.
9Scanlon PJ, Fason DP, Audet AM, et al. ACC/AHA guidelines for coronary angiography:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committeeon Comary Angiography)[J] .J Am Coll Cardiol, 1999,35(5):1156.
10Eagle KA, Guyton RA, Nugent WC, et al. ACC/AHA Guidelines for coronary artery bypass graft surgery:a report of the American College of Cardlology/American Hear Association Task Force on Practice Guidelines (Committee to revise the 1991 Guidelines for coronary artery bypass graft surgery)[J]J Am Coil Cardiol. 1999,35(9):2262.
